Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Brentuximab Vedotin”

185 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 185 results

Testing effectiveness (Phase 2)Ended earlyNCT02689219
What this trial is testing

Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors

Who this might be right for
Germ Cell TumorsTestis CancerTesticular Cancer+2 more
Nabil Adra 18
Not applicableStudy completedNCT04213209
What this trial is testing

Special Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion "Relapsed or Refractory CD30-positive Peripheral T Cell Lymphoma or Pediatric Hodgkin Lymphoma"

Who this might be right for
Peripheral T Cell LymphomaPediatric Hodgkin Lymphoma
Takeda 95
Testing effectiveness (Phase 2)UnknownNCT05006664
What this trial is testing

Brentuximab Vedotin in Combination With CHEP in Patient With PTCL

Who this might be right for
Lymphoma, T-Cell, Peripheral
Czech Lymphoma Study Group 33
Testing effectiveness (Phase 2)Study completedNCT02939014
What this trial is testing

Brentuximab Vedotin in Chinese Participants With Relapsed/Refractory CD30-Positive Hodgkin Lymphoma (HL) or Systemic Anaplastic Large Cell Lymphoma (sALCL)

Who this might be right for
Hodgkin DiseaseLymphoma, Large-Cell, Anaplastic
Takeda 39
Testing effectiveness (Phase 2)Ended earlyNCT02594163
What this trial is testing

Study of Rituximab and Bendamustine With or Without Brentuximab Vedotin for CD30 Positive Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma RefractoryFollicular B-cell Non-Hodgkin's Lymphoma
Seagen Inc. 25
Testing effectiveness (Phase 2)Study completedNCT01421667
What this trial is testing

Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma

Who this might be right for
Lymphoma, B-CellLymphoma, Large B-Cell, DiffuseLymphoma, Non-Hodgkin+1 more
Seagen Inc. 176
Early research (Phase 1)Ended earlyNCT01940796
What this trial is testing

Phase I Trial of Brentuximab Vedotin for Refractory Chronic Graft-vs.-Host Disease (GVHD)

Who this might be right for
Graft-vs-Host DiseaseGVHD
Massachusetts General Hospital 19
Not applicableLooking for participantsNCT05481437
What this trial is testing

A Survey of Brentuximab Vedotin in Pediatric Participants With Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Takeda 8
Not applicableStudy completedNCT07145125
What this trial is testing

Real-life Efficacy and Toxicity of Brentuximab-Vedotin Associated With Bendamustine in Patients With Relapsed or Refractory Hodgkin Lymphoma (HL-R2-B2)

Who this might be right for
Relapsed or Refractory Hodgkin Lymphoma
University Hospital, Bordeaux 222
Testing effectiveness (Phase 2)Study completedNCT02191930
What this trial is testing

Brentuximab Vedotin or B-CAP in the Treatment of Older Patients With Newly Diagnosed Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
University of Cologne 70
Testing effectiveness (Phase 2)WithdrawnNCT01620229
What this trial is testing

Brentuximab Vedotin After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Hematopoietic/Lymphoid Cancer
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT04138875
What this trial is testing

A Risk Stratified Sequential Treatment With Rituximab, Brentuximab Vedotin and Bendamustine (RBvB)

Who this might be right for
PTLDLymphoid TumorHematopoietic/Lymphoid Cancer+6 more
Yale University
Testing effectiveness (Phase 2)Study completedNCT02572167
What this trial is testing

Brentuximab Vedotin Combined With Nivolumab for Relapsed or Refractory Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Seagen Inc. 93
Testing effectiveness (Phase 2)Ended earlyNCT02533570
What this trial is testing

Dose Ranging Study of Brentuximab Vedotin in Adults With Lupus

Who this might be right for
Systemic Lupus Erythematosus
Seagen Inc. 20
Testing effectiveness (Phase 2)Study completedNCT02505269
What this trial is testing

Brentuximab Vedotin Plus AD in Non-bulky Limited Stage Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Massachusetts General Hospital 34
Not applicableStudy completedNCT03729609
What this trial is testing

Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion "Untreated CD30-Positive Hodgkin's Lymphoma"

Who this might be right for
Untreated CD30-Positive Hodgkin's Lymphoma
Takeda 113
Testing effectiveness (Phase 2)Study completedNCT02243436
What this trial is testing

Brentuximab Vedotin in Pre-transplant Induction and Consolidation for Relapsed or Refractory Hodgkin Lymphoma

Who this might be right for
CLASSICAL HODGKIN LYMPHOMA
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea 67
Testing effectiveness (Phase 2)Study completedNCT00866047
What this trial is testing

Open Label Trial of Brentuximab Vedotin (SGN-35) for Systemic Anaplastic Large Cell Lymphoma

Who this might be right for
Lymphoma, Large-Cell, AnaplasticLymphoma, Non-Hodgkin
Seagen Inc. 58
Testing effectiveness (Phase 2)Ended earlyNCT03646123
What this trial is testing

Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Seagen Inc. 255
Large-scale testing (Phase 3)Enrolling By InvitationNCT07258680
What this trial is testing

BrEto-TCL - Defining the Role of Brentuximab and Etoposide for Optimizing First-line Therapy of T-cell Lymphomas

Who this might be right for
Peripheral T-cell Lymphoma
N.N. Petrov National Medical Research Center of Oncology 114
Load More Results